Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.33, $0.01 better than the analyst estimate of $1.32. Revenue for the quarter came in at $5.09 billion versus the consensus estimate of $5.22 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2019 EPS of $5.60-$5.70, versus the consensus of $5.64.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.